Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of DKK 196.59 billion. The enterprise value is 218.43 billion.

Market Cap	196.59B
Enterprise Value	218.43B

Important Dates

The last earnings date was Tuesday, November 5, 2024.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	Dec 6, 2024

Share Statistics

Coloplast has 225.14 million shares outstanding. The number of shares has increased by 4.36% in one year.

Current Share Class	n/a
Shares Outstanding	225.14M
Shares Change (YoY)	+4.36%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	5.66%
Owned by Institutions (%)	24.30%
Float	141.36M

Valuation Ratios

The trailing PE ratio is 38.88 and the forward PE ratio is 33.81. Coloplast's PEG ratio is 2.91.

PE Ratio	38.88
Forward PE	33.81
PS Ratio	7.27
PB Ratio	10.96
P/TBV Ratio	n/a
P/FCF Ratio	122.87
P/OCF Ratio	n/a
PEG Ratio	2.91

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.76, with an EV/FCF ratio of 136.52.

EV / Earnings	43.24
EV / Sales	8.08
EV / EBITDA	25.76
EV / EBIT	29.88
EV / FCF	136.52

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.26.

Current Ratio	1.02
Quick Ratio	0.62
Debt / Equity	1.26
Debt / EBITDA	2.67
Debt / FCF	14.14
Interest Coverage	9.19

Financial Efficiency

Return on equity (ROE) is 28.67% and return on invested capital (ROIC) is 11.80%.

Return on Equity (ROE)	28.67%
Return on Assets (ROA)	9.49%
Return on Capital (ROIC)	11.80%
Revenue Per Employee	1.62M
Profits Per Employee	303,624
Employee Count	15,692
Asset Turnover	0.56
Inventory Turnover	2.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.12% in the last 52 weeks. The beta is 0.33, so Coloplast's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	+17.12%
50-Day Moving Average	890.87
200-Day Moving Average	887.44
Relative Strength Index (RSI)	45.06
Average Volume (20 Days)	161,030

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Coloplast had revenue of DKK 27.03 billion and earned 5.05 billion in profits. Earnings per share was 22.46.

Revenue	27.03B
Gross Profit	18.27B
Operating Income	7.31B
Pretax Income	6.40B
Net Income	5.05B
EBITDA	8.19B
EBIT	7.31B
Earnings Per Share (EPS)	22.46

Full Income Statement

Balance Sheet

The company has 788.00 million in cash and 22.63 billion in debt, giving a net cash position of -21.84 billion or -97.01 per share.

Cash & Cash Equivalents	788.00M
Total Debt	22.63B
Net Cash	-21.84B
Net Cash Per Share	-97.01
Equity (Book Value)	17.94B
Book Value Per Share	79.69
Working Capital	240.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.77 billion and capital expenditures -1.17 billion, giving a free cash flow of 1.60 billion.

Operating Cash Flow	2.77B
Capital Expenditures	-1.17B
Free Cash Flow	1.60B
FCF Per Share	7.11

Full Cash Flow Statement

Margins

Gross margin is 67.59%, with operating and profit margins of 27.04% and 18.69%.

Gross Margin	67.59%
Operating Margin	27.04%
Pretax Margin	23.66%
Profit Margin	18.69%
EBITDA Margin	30.30%
EBIT Margin	27.04%
FCF Margin	5.92%

Dividends & Yields

This stock pays an annual dividend of 22.00, which amounts to a dividend yield of 2.50%.

Dividend Per Share	22.00
Dividend Yield	2.50%
Dividend Growth (YoY)	5.00%
Years of Dividend Growth	11
Payout Ratio	93.43%
Buyback Yield	-4.36%
Shareholder Yield	-1.86%
Earnings Yield	2.57%
FCF Yield	0.81%

Dividend Details

Stock Splits

The last stock split was on December 19, 2012. It was a forward split with a ratio of 5.

Last Split Date	Dec 19, 2012
Split Type	Forward
Split Ratio	5

Scores

Coloplast has an Altman Z-Score of 5.4.

Altman Z-Score	5.4
Piotroski F-Score	n/a